JSCGX vs. NCLEX
JSCGX (Jacob Small Cap Growth Fund) and NCLEX (Nicholas Limited Edition Fund) are both Small Cap Growth Equities funds. Over the past 10 years, JSCGX returned 7.58%/yr vs 7.62%/yr for NCLEX. Their correlation of 0.80 suggests significant overlap in exposure. JSCGX charges 1.97%/yr vs 0.85%/yr for NCLEX.
Performance
JSCGX vs. NCLEX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JSCGX achieves a -21.62% return, which is significantly lower than NCLEX's -0.91% return. Both investments have delivered pretty close results over the past 10 years, with JSCGX having a 7.58% annualized return and NCLEX not far ahead at 7.62%.
JSCGX
- 1D
- -1.21%
- 1M
- 8.72%
- 6M
- -22.52%
- YTD
- -21.62%
- 1Y
- 2.27%
- 3Y*
- 9.50%
- 5Y*
- -8.48%
- 10Y*
- 7.58%
NCLEX
- 1D
- 0.04%
- 1M
- 5.82%
- 6M
- -5.07%
- YTD
- -0.91%
- 1Y
- -6.44%
- 3Y*
- 1.20%
- 5Y*
- -0.46%
- 10Y*
- 7.62%
JSCGX vs. NCLEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JSCGX Jacob Small Cap Growth Fund | -21.62% | 41.65% | 12.89% | 18.74% | -50.37% | -0.60% | 60.95% | 20.04% | 8.26% | 20.61% |
NCLEX Nicholas Limited Edition Fund | -0.91% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 27.36% | -0.94% | 19.93% |
Correlation
The correlation between JSCGX and NCLEX is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.70 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.74 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.78 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2010 | 0.80 |
The correlation between JSCGX and NCLEX shifts across timeframes, from 0.69 (1 year) to 0.80 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JSCGX vs. NCLEX — Risk / Return Rank
JSCGX
NCLEX
JSCGX vs. NCLEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jacob Small Cap Growth Fund (JSCGX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JSCGX | NCLEX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.50 | ||
| Sortino ratioReturn per unit of downside risk | +0.80 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 0.93 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.01 | -0.40 | +0.41 |
| Martin ratioReturn relative to average drawdown | 0.02 | -0.80 | +0.81 |
Loading charts...
Drawdowns
JSCGX vs. NCLEX - Drawdown Comparison
The maximum JSCGX drawdown since its inception was -70.07%, which is greater than NCLEX's maximum drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for JSCGX and NCLEX.
Loading charts...
Drawdown Indicators
| JSCGX | NCLEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.07% | -48.68% | -21.39% |
Max Drawdown (1Y)Largest decline over 1 year | -32.69% | -20.88% | -11.81% |
Max Drawdown (3Y)Largest decline over 3 years | -32.69% | -28.50% | -4.19% |
Max Drawdown (5Y)Largest decline over 5 years | -67.86% | -28.50% | -39.36% |
Max Drawdown (10Y)Largest decline over 10 years | -70.07% | -35.79% | -34.28% |
Current DrawdownCurrent decline from peak | -45.65% | -17.10% | -28.55% |
Average DrawdownAverage peak-to-trough decline | -25.23% | -8.31% | -16.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.97% | 10.59% | +6.38% |
Volatility
JSCGX vs. NCLEX - Volatility Comparison
Jacob Small Cap Growth Fund (JSCGX) has a higher volatility of 6.88% compared to Nicholas Limited Edition Fund (NCLEX) at 4.95%. This indicates that JSCGX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JSCGX | NCLEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.88% | 4.95% | +1.93% |
Volatility (6M)Calculated over the trailing 6-month period | 21.32% | 12.67% | +8.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.14% | 17.20% | +11.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.34% | 19.60% | +16.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.76% | 19.19% | +13.57% |
JSCGX vs. NCLEX - Expense Ratio Comparison
JSCGX has a 1.97% expense ratio, which is higher than NCLEX's 0.85% expense ratio.
Dividends
JSCGX vs. NCLEX - Dividend Comparison
JSCGX has not paid dividends to shareholders, while NCLEX's dividend yield for the trailing twelve months is around 7.60%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JSCGX Jacob Small Cap Growth Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.09% | 13.69% | 2.57% | 1.13% | 0.00% | 0.00% | 0.59% |
NCLEX Nicholas Limited Edition Fund | 7.60% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Frequently Asked Questions
JSCGX and NCLEX have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JSCGX has higher volatility (6.88%) compared to NCLEX (4.95%). In terms of maximum drawdown, JSCGX dropped -70.07% vs NCLEX's -48.68%.
JSCGX currently has the higher Sharpe Ratio (0.01 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JSCGX and NCLEX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer